Clinical Trial Update: A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved [Phase 3]

View source ↗

Summary

Phase 3 trial in adolescents and adults with eosinophilic esophagitis evaluating histologic response and dysphagia outcomes; results were posted in March 2020. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Jorveza (budesonide)

Snippet

Sponsor: Shire | Conditions: Eosinophilic Esophagitis (EoE) | Phase 3 | Status: COMPLETED | Results posted: 2020-03-16